Forget Livongo: This is a better telehealth stock

The financial world was buzzing in August when Teladoc purchased Livongo Health for an eye-popping $18.5 billion. While both companies were thriving -- Livongo was more than doubling sales every year, and Teladoc was also growing fast and increasing its network of members and providers -- some investors worried that this was far too high a price for an acquisition at the height of a once-in-a-century pandemic.